Board to consider Final Dividend
Jyothy Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 23, 2016, inter alia, to consider and approve Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended March 31, 2016 and to consider and recommend final dividend, if any, on the Equity Shares of the Company for the financial year 2015-16. Shareholding for the Period Ended March 31, 2016
Jyothy Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2016. For more details, kindly Click here Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended March 31, 2016
Jyothy Laboratories Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended March 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
M P Ramachandran has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE Opening/ Closing of Trading Window for purchase/ sale of shares of the Company
Jyothy Laboratories Ltd has informed BSE that pursuant to clause 5 of the Code of Conduct for regulating, monitoring and reporting of trading by insiders of the Company, trading window to deal in Company shares is closed for designated persons from April 01, 2016 till the end of forty eight hours after the financial results for the 4th Quarter and Financial Year ending March 31, 2016 become generally available. Board declares Interim Dividend
Jyothy Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 10, 2016, recommended Interim Dividend of Rs. 4.00 (Rupees Four Only) per equity share of Re. 1/- each for the financial year 2015-16.The aforesaid dividend will be paid to the equity shareholders of the Company as on Record Date (i.e. March 18, 2016) and will be paid/ Dividend Warrant dispatched before March 31, 2016. Allotment of Equity Shares under Jyothy Laboratories Employees Stock Options Scheme
Jyothy Laboratories Ltd has informed BSE that the ESOP Allotment Committee of Board of Directors of the Company in its meeting held on March 07, 2016 has issued and allotted 6,558 (Six Thousand Five Hundred and Fifty Eight) Equity Shares of face value of Re.1/- each to the eligible employee of the Company under Jyothy Laboratories Employees Stock Options Scheme (ESOS 2014). Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
M P Ramachandran has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE Fixes Record Date for Interim Dividend
Jyothy Laboratories Ltd has informed BSE that the Company has fixed March 18, 2016 as the Record Date for the purpose of Payment of Interim Dividend, if declared. Board to consider Interim Dividend
Jyothy Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on March 10, 2016, inter alia, to consider the declaration of Interim Dividend on the Equity Shares of the Company for the financial year 2015-16.Further, pursuant to Clause 5 of the Code of Conduct for regulating, monitoring and reporting of trading by insiders of the Company, trading window to deal in Company securities shall remain...